Precision Imaging for Particle Therapy & Nuclear Medicine

Precision imaging for nuclear medicine and next-generation particle therapy

Terapet develops advanced gamma-ray detection systems designed to support treatment verification and next-generation clinical imaging. Our technologies connect treatment planning, biological processes, and measurable clinical insights.

Bringing scientific rigor and measurable precision into clinical practice.

From simulation to patient-specific validation

In many clinical workflows, treatments are carefully planned, but not directly verified. This creates a gap between what is expected and what actually occurs at the patient level. Terapet develops imaging technologies that make this information accessible, providing clinicians with reliable data after treatment and supporting more informed therapeutic decisions.

Across multiple fields.
One commitment to precision.

Terapet’s technologies are used in particle therapy and nuclear medicine, with the potential to extend to emerging applications where imaging supports more precise, data-driven approaches to diagnosis and treatment.

Particle Therapy

PET-based systems for quality assurance and post-irradiation verification, supporting a more precise assessment of beam delivery and treatment execution.

Nuclear Medicine

Next-generation PET imaging technologies for oncology, clinical trials and future precision medicine applications, designed to combine high performance with scalable deployment.

Our products

A portfolio of PET-based imaging solutions addressing key challenges in particle therapy, nuclear medicine, and a growing range of applications.

Particle

QUALYSCAN® QA

PET system for machine and patient quality assurance in particle therapy, enabling activity measurement in phantoms and comparison with reference distributions.

Particle

QUALYSCAN® In Vivo

PET system for patient-specific verification in particle therapy, enabling in vivo measurement of treatment-induced activity and closing the loop between planned and delivered treatment.

Particle

QUALYSCAN® Upright

PET system for patient-specific verification in upright particle therapy, enabling in vivo measurement of treatment-induced activity and closing the loop between planned and delivered treatment in upright position.

Nuclear

NUCLYSCAN®

Total-body PET system for nuclear medicine, supporting high-sensitivity imaging of biological processes and quantitative whole-body assessment across clinical and research applications, with a scalable and cost-efficient design.

Nuclear

Coming soon

Nuclear

Coming soon

Treatment verification based on measured data

Terapet’s approach goes beyond conventional validation workflows. By measuring activity and comparing it with expected distributions, our technologies provide a direct view of what actually happens at the patient level.

Founded in Geneva. Collaborating worldwide.

Terapet operates internationally from its headquarters in Geneva, collaborating with leading hospitals, research institutes, and industry partners across Europe, US and Asia. With installations and validation activities in Sweden and South Korea, and expanding partnerships in Germany and Japan, the company brings its technologies into particle therapy, nuclear medicine, and a wide range of applications requiring precise, patient-specific imaging.